Log in  First Connection?

Psoriasis: Archives News of the month

Real‐world safety and efficacy of biologics in elderly patients with psoriasis: A multicenter observational study
Psoriasis
 4 min.

 Published on 29/07/2024 |  Original article (Abstract)  | Chika Ohata et al. | The Journal of Dermatology 2024; 51(12): 1634-40

Psoriasis is a chronic, inflammatory disorder that affects both the skin and joints, and is mediated by the immune system. Its global prevalence varies regionally, ranging from 0.14%–1.99%. A database study reported a 0.34% estimated occurrence of psoriasis in Japan. The paradigm shift has occurred...

Efficacy of probiotic supplementation in the treatment of psoriasis—A systematic review and meta‐analysis
Psoriasis
 3 min.

 Published on 22/07/2024 |  Original article (Abstract)  | Kebo Wei MM et al. | Journal of Cosmetic Dermatology 2024; 23(7): 2361-7

Psoriasis is an inflammatory skin disease that seriously affects the physical and mental health of humans. Some patients may also be accompanied by severe itching. It is commonly associated with genetics, immune disorders, infections, environmental factors, and endocrine factors. It is reported that...

Novel pharmacotherapies and breakthroughs in psoriasis treatment: 2024 and beyond
Psoriasis
 1 min.

 Published on 15/07/2024 |  Original article (Abstract)  | Antonio Portarapillo et al. | Expert Opinion on Pharmacotherapy 2024; aop:10.1080/14656566.2024.2373354

The use of the current available therapies for psoriasis management may sometimes be limited by reduced patients' compliance, safety issues for patients' comorbidities, primary lack of efficacy, loss of effectiveness, development of side effects. In this context, several clinical trials investigating...

Association between lipid accumulation product and psoriasis among adults: a nationally representative cross-sectional study
Psoriasis
 5 min.

 Published on 08/07/2024 |  Original article (Abstract)  | Zhang Caiyun et al. | Lipids in Health and Disease 2024; 23(1): 143

Approximately 3.0% of the United States (U.S.) adult population suffers from psoriasis, a prevalent immune-mediated disease [1]. The incidence of psoriasis is comparable in women and men. The two peak age ranges for psoriasis are 18 to 39 and 50 to 69 years, although it can develop at any age [2]. It...

Automatic evaluation of Nail Psoriasis Severity Index using deep learning algorithm
Psoriasis
 4 min.

 Published on 01/07/2024 |  Original article (Abstract)  | Kyungho Paik et al. | The Journal of Dermatology 2024; 51(10): 1310-7

Nail psoriasis is a common manifestation of psoriasis that causes changes in the nail, including pitting, leukonychia, subungual hyperkeratosis, and onycholysis. Nail psoriasis is clinically significant, as its presence is often associated with the development of psoriatic arthritis, making its accurate...